W.A.J. Poppe

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Jorma Paavonen, Paulo Naud, Jorge Salmerón et al. · The Lancet · 2009 · 1.6K citations

As04-adjuvanted Vaccine, Gynecology, Oncogenic Hpv Types +16

Efficacy of the human papillomavirus (HPV)‐16/18 AS04‐adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV‐16/18

Anne Szarewski, W.A.J. Poppe, S. Rachel Skinner et al. · International Journal of Cancer · 2011 · 138 citations · Full text

Previous Exposure, Gynecology, Cervical Cancer Prevention +23

Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation

Anne Szarewski, S. Rachel Skinner, Suzanne M. Garland et al. · The Journal of Infectious Diseases · 2013 · 81 citations · Full text

The Clinical Role of HPV Testing in Primary and Secondary Cervical Cancer Screening

Griet Hoste, Karlien Vossaert, W.A.J. Poppe · Obstetrics and Gynecology International · 2013 · 39 citations · Full text

Gynecology, Pathology, Cytopathology +20

Langerhans’ Cells and L1 Antigen Expression in Normal and Abnormal Squamous Epithelium of the Cervical Transformation Zone

W.A.J. Poppe, M. Drijkoningen, P. Ide et al. · Gynecologic and Obstetric Investigation · 1996 · 26 citations

Tobacco Control, Cervical Cancer, Immunology +15